硬化症

yìnɡ huà zhènɡ
  • sclerosis
硬化症硬化症
  1. 基于马尔可夫场的多发性硬化症MR图像分割算法

    Segmentation of Multiple Sclerosis Lesions Based on Markov Random Fields Model for MR Images

  2. 日本系统性硬化症患者中的抗DNA拓扑异构酶Ⅱα自身抗体

    Anti - DNA topoisomerase ⅱ α autoantibodies in Japanese patients with systemic sclerosis

  3. 肌萎缩性脊髓侧索硬化症通常被称为葛雷克氏症,是以曾经患有此症的一位棒球运动员的名字命名的。

    It is commonly called Lou Gehrig 's disease , after the baseball player who had it .

  4. 多层螺旋CT仿真血管镜在动脉硬化症诊断中的临床应用

    Clinical Application of Multi-Slice CT Virtual Intravascular Endoscopy in Diagnosis of Arteriosclerosis

  5. 小儿结节性硬化症的临床及颅脑CT表现

    Clinical and CT manifestations of tuberous sclerosis in children

  6. 系统性硬化症肺部高分辨率CT表现

    HRCT of the lung in systemic sclerosis

  7. MRI及MR扩散张量成像对肌萎缩侧索硬化症的初步评价

    Preliminary assessment of amyotrophic lateral sclerosis by using MRI and MR diffusion tensor imaging

  8. 多发性硬化症疾病异质性的MRI标志

    MRI as a marker for disease heterogeneity in multiple sclerosis

  9. 结节性硬化症的CT和MRI影像学表现(20例报告)

    CT and MRI imaging of tuberous sclerosis complex ( report of 20 cases )

  10. 91例肌萎缩侧索硬化症的F波和神经传导研究

    F-wave and Nerve Conduction Studies in 91 Patients with Amyotrophic Lateral Sclerosis

  11. 多发性硬化症患者年龄相关性脑损伤的钆增强MRI表现

    Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis

  12. 结节性硬化症的CT、MRI诊断

    CT and MRI Diagnosis of Tuberous Sclerosis

  13. 目的:分析结节性硬化症脑部CT和MRI表现,以提高对本病的认识。

    Objective : To study the CT and MRI findings of cerebral tuberous sclerosis complex .

  14. 方法:收集经临床及CT诊断的结节性硬化症35例,分析其颅脑及肾脏CT表现。

    Methods : CT presentations of brain and kidney were analyzed in 35 cases of tuberous sclerosis .

  15. 增加干扰素β-1a剂量和频率治疗复发性多发性硬化症提高药物疗效的EVIDENCE研究

    Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis : The EVIDENCE study

  16. 多发性硬化症临床表现与MRI分析

    Clinical Manifestation and MRI Analysis of Multiple Sclerosis

  17. 闭塞性动脉硬化症如脉压(PP)是动脉硬化的晚期标志;

    For example , pulse pressure ( PP ) is an advanced sign of afternoon arteriosclerosis ;

  18. 爱尔兰人群HLA单体型发病率在多发性硬化症患病率差异中的作用

    Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland

  19. 早期发病的多发性硬化症患者CSF的特征

    CSF characteristics in early - onset multiple sclerosis

  20. 多发性硬化症脑脱髓鞘病灶TGF-β1和bFGF的表达

    Expression of TGF β 1 and bFGF in cerebral demyelinating focuses of multiple sclerosis

  21. 上海地区多发性硬化症与HLAⅡ类基因和抗原处理相关基因关联研究

    Association between multiple sclerosis and HLA class II and antigen processing genes in a Shanghai population

  22. 多发性硬化症(MS)是一种慢性中枢神经系统疾病,目前在临床上难以治愈。

    Multiple sclerosis ( MS ) is a chronic disease of central nervous system and so far there is no cure for MS.

  23. 多发性硬化症与自身免疫性疾病:意大利东北部人群流行病学与HLA-DR之间的联系

    Multiple sclerosis and autoimmune diseases : Epidemiology and HLA-DR association in North-east Italy

  24. EB病毒和多发性硬化症:一项长期随访前瞻性研究的关联性证据

    Epstein-Barr virus and multiple sclerosis : Evidence of association from a prospective study with long-term follow-up

  25. 抗Ku抗体对系统性硬化症并多发性肌炎的特异性为99.4%。

    The specificity of anti Ku antibodies for diagnosis of SSc PM was 99.4 % .

  26. 目的寻找脑动脉硬化症(CAS)的早期指标,以利尽早防止CAS的发生。

    Objective To find the early stage index of cerebral arteriosclerosis ( CAS ) in order to prevent its occurrence .

  27. 背景:多发性硬化症(MS)是一种中枢神经系统(CNS)脱髓鞘疾病,病变多发生在视神经、脑干和脊髓等部位。

    Background : Multiple sclerosis is a neurological demyelinating disease , which tends to attack the optic nerve , brain stem and spinal cord .

  28. 结论:CT及MRI检查对结节性硬化症的诊断具有重要价值,结合临床特点及脑内特征改变对其特殊表现可做出定性诊断。

    Con clu-sion : CT and MRI examinations have important value in the diagnosis of TSC , the characteristic imaging appearances with clinical features usually can make a specific TSC diagnosis .

  29. 结论抗Ku抗体是系统性硬化症并多发性肌炎重叠结缔组织病的相对特异性抗体。

    Conclusion The anti Ku antibody is relatively specific for systemic sclerosis polymyositis overlap connective tissue disease .

  30. 重组人干扰素β1b治疗复发缓解型多发性硬化症的安全性及临床疗效

    Safety and Clinical Efficacy of Recombinant Human Interferon β 1b for Treatment of Relapsing-Remitting Multiple Sclerosis